Consensus $204.43M. The company said, “Cytek Biosciences (CTKB) revises its 2025 revenue guidance of full year 2025 revenue to be in the range of $196 million to $210 million, representing growth of -2% to 5% over full year 2024, assuming no change in currency exchange rates.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTKB: